| Quarter | Prior | Estimate | Actual | Surprise | |
|---|---|---|---|---|---|
| Q1 2022 After-Hours | EPS: REV: | ||||
| Q4 2021 After-Hours | EPS: REV: | ||||
| Q3 2021 Pre-Market | EPS: REV: | ||||
| Q2 2021 Pre-Market | EPS: REV: | ||||
| Q1 2021 After-Hours | EPS: REV: | 0.2 165.89M | 0.31 195.019M | 55% 17.56% | |
| Q4 2020 After-Hours | EPS: REV: | 180.96M | 1 226.14M | 24.97% | |
| Q3 2020 After-Hours | EPS: REV: | 0.28 130.837M | 0.2 149.83M | 0.4 166.442M | 100% 11.09% |
| Q2 2020 After-Hours | EPS: REV: | 0.14 112.362M | 0.16 133.36M | -0.01 141.259M | -106.25% 5.92% |
| Q1 2020 After-Hours | EPS: REV: | 0.21 115.81M | 0.18 131.97M | 0.4 147.162M | 122.22% 11.51% |
| Q4 2019 After-Hours | EPS: REV: | 0.08 114.791M | 0.38 146.31M | 0.41 171.851M | 7.89% 17.46% |
Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!
News Coverage
- Mid-Day Market Update: Crude Oil Rises Over 1%; Orphazyme Shares Plunge
- Birks FY21 Earnings Impacted By COVID-19 Restrictions
- Mid-Morning Market Update: Markets Open Lower; Adobe Reports Upbeat Q2 Earnings
- Friday's Market Minute: Inflation Meets A Complacent Market
- Investors May Continue Keeping An Eye On Bank Stocks As Long-Term Yields Drop
- The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs
- Codexis Raises 2021 Revenue Outlook After New Order For Its Enzyme Product
- A Peek Into The Markets: US Stock Futures Edge Higher; Adobe Profit Beats Views
- 5 Stocks To Watch For June 18, 2021
- Smith & Wesson Brands: Q4 Earnings Insights
